General aspects of lead finding and optimization in drug discovery (2007)
- Autores:
- Autor USP: CARLOS HENRIQUE TOMICH DE PAULA DA SILVA - FCFRP
- Unidade: FCFRP
- Assunto: FARMACOLOGIA
- Idioma: Inglês
- Imprenta:
- Editora: Research Signpost
- Local: Kerala
- Data de publicação: 2007
- ISBN: 81-308-0141-8
- Fonte:
- Título do periódico: Current Methods in Medicinal and Biological Physics
-
ABNT
SILVA, Carlos Henrique Tomich de Paula da e LEOPOLDINO, Andréia Machado e TAFT, Carlton A. General aspects of lead finding and optimization in drug discovery. Current Methods in Medicinal and Biological Physics. Tradução . Kerala: Research Signpost, 2007. . . Acesso em: 18 abr. 2024. -
APA
Silva, C. H. T. de P. da, Leopoldino, A. M., & Taft, C. A. (2007). General aspects of lead finding and optimization in drug discovery. In Current Methods in Medicinal and Biological Physics. Kerala: Research Signpost. -
NLM
Silva CHT de P da, Leopoldino AM, Taft CA. General aspects of lead finding and optimization in drug discovery. In: Current Methods in Medicinal and Biological Physics. Kerala: Research Signpost; 2007. [citado 2024 abr. 18 ] -
Vancouver
Silva CHT de P da, Leopoldino AM, Taft CA. General aspects of lead finding and optimization in drug discovery. In: Current Methods in Medicinal and Biological Physics. Kerala: Research Signpost; 2007. [citado 2024 abr. 18 ] - Química computacional no planejamento de candidatos a quimioterápicos
- Planejamento racional de inibidores de enzimas-alvo aplicado a diferentes doenças: modelagem, síntese, bioquímica e QSAR
- RNA interference in drug discovery
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms
- Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia
- Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches
- Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase
- Molecular dynamics, density functional theory, pharmacophore modeling, molecular interaction fields and ADME/tox investigation of novel bioactive compounds interacting with CDK2 surfaces
- Pharmacophore-based drug design of novel potential tau ligands for Alzheimer's disease treatment
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
